CS logo
small CS logo
Hacettepe University Hospital

Ankara, Turkey
Hospital in Ankara
Hacettepe, A.Adnan Saygun Cd, 06230 Altındağ/Ankara

About Hacettepe University Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hacettepe University
6
Janssen Research & Development, LLC
6
PTC Therapeutics
2
BioNTech SE
1
Biogen
1
Ellipse Technologies, Inc.
1
Foresee Pharmaceuticals Co., Ltd.
1
Janssen Sciences Ireland UC
1
The Hospital for Sick Children
1
Total Rows: 9

Clinical Trials at Hacettepe University Hospital


During the past decade, Hacettepe University Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11222244440000220000Started TrialsCompleted Trails201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effectiveness of Physiotherapy on Postcesarean Pain and Functional Activities
2004-12-01
2005-05-01
Completed
50
A Study Comparing Two Treatments for Infants With Hydrocephalus
2005-09-01
2018-05-01
Completed
182
A Retrospective Review of Early Onset Spinal Deformity Patients Treated With the Ellipse MAGEC System
2012-07-01
2013-01-01
Completed
54
Total Versus Partial Arytenoidectomy in Bilateral Vocal Fold Paralysis
2011-01-01
2012-09-01
Completed
20
Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)
2013-03-26
2015-08-20
Completed
230
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
2014-03-20
2018-06-12
Terminated
219
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy
2014-08-19
2016-11-21
Terminated
122
Predictors of Difficult Videolaryngoscopy
2018-01-17
2020-03-01
Completed
1,159

Rows per page:

1–20 of 20

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hacettepe University Hospital" #1 sponsor was "Hacettepe University" with 6 trials, followed by "Janssen Research & Development, LLC" with 6 trials sponsored, "PTC Therapeutics" with 2 trials sponsored, "BioNTech SE" with 1 trials sponsored and "Biogen" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hacettepe University Hospital" #1 collaborator was "The International Society for Pediatric Neurosurgery" with 1 trials as a collaborator and "The International Study Group for Neuroendoscopy (ISGNE)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHacettepe University: 6Hacettepe University: 6Janssen Research &Development, LLC: 6Janssen Research &Development, LLC: 6PTC Therapeutics: 2PTC Therapeutics: 2BioNTech SE: 1BioNTech SE: 1Biogen: 1Biogen: 1Ellipse Technologies, Inc.: 1Ellipse Technologies, Inc.: 1ForeseePharmaceuticals Co.,Ltd.: 1ForeseePharmaceuticals Co.,Ltd.: 1Janssen Sciences Ireland UC: 1Janssen Sciences Ireland UC: 1The Hospital for Sick Children: 1The Hospital for Sick Children: 1

Created with Highcharts 11.1.0Top CollaboratorsThe InternationalSociety for PediatricNeurosurgery: 1The InternationalSociety for PediatricNeurosurgery: 1The International StudyGroup forNeuroendoscopy(ISGNE): 1The International StudyGroup forNeuroendoscopy(ISGNE): 1

Clinical Trials Conditions at Hacettepe University Hospital


According to Clinical.Site data, the most researched conditions in "Hacettepe University Hospital" are "COVID-19" (2 trials), "Genetic Diseases, Inborn" (2 trials), "Genetic Diseases, X-Linked" (2 trials), "Hepatitis B, Chronic" (2 trials) and "Muscular Diseases" (2 trials). Many other conditions were trialed in "Hacettepe University Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Hacettepe University Hospital


Most popular intervention types in "Hacettepe University Hospital" are "Drug" (11 trials), "Biological" (3 trials), "Device" (3 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Guselkumab" (3 trials), "JNJ-73763989" (3 trials), "Ataluren" (2 trials) and "Golimumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Hacettepe University Hospital


The vast majority of trials in "Hacettepe University Hospital" are 16 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Clinical Trials Status at Hacettepe University Hospital


Currently, there are NaN active trials in "Hacettepe University Hospital". 1 are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hacettepe University Hospital, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Hacettepe University Hospital, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 9Phase 2: 9Not Applicable: 5Not Applicable: 5Phase 3: 5Phase 3: 5Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 8Completed: 8Recruiting: 5Recruiting: 5Active, not recruiting: 4Active, not recruiting: 4Terminated: 2Terminated: 2Not yet recruiting: 1Not yet recruiting: 1